Replies to post #34740 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

I'm not freaking out at all. I'm simply pointing out how stupid and illogical it is at this grave stage for mgmt. to continue not bothering to inform the market if/when actual material progress on anything in their stagnant pipeline starts to occur.

And you're more than welcome to disagree with my view mopar...but considering mgmt.'s performance since last July...they need to be a hell of a lot more accountable to market than they're being.

And their earlier guidance given in previous years is precisely what the market judges them by...so just because they gave new guidance in January doesn't mean anything to the market masses and ongoing market apathy plaguing their stock. If they would get their heads outta their collective butts they'd know that!

[doogdilinger]

Also there's nothing irrational about demanding mgmt. starts doing a hell of a lot better job at their storyline messaging than they've been doing over the past 4+ years since their original CFO Shameze departed the scene.

What's irrational at this grave stage is putting the blinders on and thinking the market apathy plaguing this stock is simply going to go away with mgmt. not bothering to provide any actual progress or results from their stagnant pipeline.

It's not my job or anyone other joe retail market participant to contact the company to find out if they're taking their fiduciary duties and responsibilities seriously.

Launching PODRAS human trials or launching the long awaited Rexista HAP studies are definitely both material events and should therefore both be PR'd if both actually started. It's not irrational to expect mgmt. to PR progress from their stagnant pipeline if/when it finally starts to occur.